Press release
Angiography Equipment Market Research Report by Leading Key Players – General Electric Company, Siemens, Terumo Corporation, Abbott, Boston Scientific Corporation, Medtronic plc, Canon Inc., Cardinal Health, B. Braun Melsungen AG- P&S Intelligence
The global angiography equipment market is driven by factors such as rising prevalence of cardiovascular diseases (CVDs) and cancer, increasing awareness programs for cardiovascular and metabolic diseases and funding from government institutes and organizations, growing geriatric population, and surging demands of angiography systems for minimally invasive surgeries.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/angiography-equipment-market
Based on technology, the angiography equipment market is categorized into X-Ray angiography, MR angiography, CT angiography, and others (includes fluorescein angiography and optical coherence tomography angiography). X-ray angiography technology is the most widely adopted technology in the market. This is due to increasing number of interventional and diagnostic X-ray procedures.
Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/angiography-equipment-market/report-sample
The angiography equipment market is classified into coronary angiography, endovascular angiography, onco-angiography, neuro-angiography, and others, on the basis of procedure. Among all, the coronary angiography category dominates the market mainly due to the increasing prevalence of CVDs and surging aging population.
Based on indication, the angiography equipment market is classified into coronary artery disease, valvular heart disease, congestive heart failure, congenital heart disease, and others. On the basis of application, the angiography equipment is used for diagnostics and therapeutics purposes.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=angiography-equipment-market
End users in the angiography equipment market are hospitals and clinics, research institutes, and diagnostics and imaging centers. Globally, hospitals and clinics constitute the largest end-user base for angiography equipment, owing to the increasing number of admission of patients with vascular diseases in hospitals and clinics.
Geographically, Europe holds the largest share in the global angiography equipment market, due to the increasing research activities, funding and grants from government and organizations. Furthermore, increasing prevalence of cancer and CVDs in the region is driving the growth of angiography equipment market in Europe.
Some of the other key players operating in the angiography equipment industry are General Electric Company, Siemens AG, Terumo Corporation, Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Canon Inc., Cardinal Health Inc., B. Braun Melsungen AG, and AngioDynamics Inc.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angiography Equipment Market Research Report by Leading Key Players – General Electric Company, Siemens, Terumo Corporation, Abbott, Boston Scientific Corporation, Medtronic plc, Canon Inc., Cardinal Health, B. Braun Melsungen AG- P&S Intelligence here
News-ID: 1555185 • Views: …
More Releases for CVDs
Global Cardiovascular Diagnostic & Monitoring Devices Market to Reach Over USD 2 …
The global cardiovascular diagnostic & monitoring devices market, valued at USD 14.2 billion in 2021, is projected to nearly double to over USD 29.0 billion by the end of 2031, expanding at a robust CAGR of 7.5% over the forecast period (2022-2031). Fueled by the surging burden of chronic cardiovascular diseases (CVDs), demand for early diagnosis, and rapid technological advancements including AI‐enabled monitors and minimally invasive implants the market presents…
Contrast Enhanced Ultrasound Market by Product (Equipment, Nanoparticle & Molecu …
"The contrast-enhanced ultrasound market is projected to grow at a CAGR of 6.1% during the forecast period (2023-2028)."
The global contrast-enhanced ultrasound market is projected to reach USD 2.1 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 6.1% from 2023 to 2028. Factors such as rising geriatric population and increasing use of contrast agents are responsible for the increasing growth of this market. Increasing research and…
RAS-acting Agents Market to Reach US$ 13.4 Billion by 2031 Due to Increase in pr …
The global 𝗥𝗔𝗦-𝗮𝗰𝘁𝗶𝗻𝗴 𝗔𝗴𝗲𝗻𝘁𝘀 market is estimated to attain a valuation of US$ 13.4 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.2% during the forecast period, 2023-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of…
Ventricular Assist Devices Market to Reach US$ 2.80 Billion by 2027, Fueled by R …
According to the latest report by IMARC Group, titled "Ventricular Assist Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global ventricular assist devices market reached a value of US$ 1.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.80 Billion by 2027, exhibiting at a CAGR of 10.09% during 2022-2027. A ventricular assist device (VAD), also called a mechanical circulatory…
Rising Prevalence of CVDs Leads to Increasing Demand for Cardiac Biomarkers
In 2021, the cardiac biomarkers industry contributes $8,459.6 million, and it is projected to rise at a rate of 10.5%, to capture $20,718.8 million revenue in 2030. It is led by the rising prevalence of acute coronary syndrome, increasing point-of-care testing kit demand, and technological advancements in the industry.
Moreover, the surging investments in biomarker research, increasing CVDs incidences, and rising geriatric population are projected to boost the industry growth.…
Global rise in the incidence and prevalence rate of cardiovascular diseases (CVD …
Global Cardiovascular Information Systems (Cvis) Market is projected to grow at a considerable growth rate owing to increasing prevalence of CVDs across the globe. According to WHO, in 2018, CVDs accounts for 17.7 million mortality per year, which means 31% mortalities across the globe. The CVIS systems support in the assessment of chronic conditions such as CHD (coronary heart disease), stroke, and other heart related disease. CVIS systems allow assembling…
